EODData

NASDAQ, AUPH:

22 Aug 25 16:03
LAST:

12.27

CHANGE:
 0.19
OPEN:
12.13
HIGH:
12.40
ASK:
5.90
VOLUME:
2M
CHG(%):
1.57
PREV:
12.08
LOW:
12.00
BID:
5.70
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Aug 2512.1312.4012.0012.272.02M
21 Aug 2511.8912.1611.7412.081.02M
20 Aug 2512.1412.1411.8512.011.31M
19 Aug 2512.2812.3111.9212.031.17M
18 Aug 2512.3212.5312.1412.222.32M
15 Aug 2512.1412.4812.1212.272.27M
14 Aug 2511.8912.3211.7312.092.71M
13 Aug 2511.3612.1011.1812.013.09M
12 Aug 2511.4711.5911.2911.322.34M
11 Aug 2511.3611.6511.3111.432.48M

COMPANY PROFILE

Name:
About:Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:#140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6
Website:https://www.auriniapharma.com
CUSIP:05156V102
CIK:0001600620
ISIN:CA05156V1022
FIGI:BBG000BCRJM5

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:27.98
PtB:4.72
PtS:6.09
EBITDA:82.58M
Shares:131.63M
Market Cap:1.615B

TECHNICALS

MA5:12.12
MA10:11.97
MA20:11.20
MA50:9.49
MA100:8.74
MA200:8.57
STO9:78.51
STO14:78.51
RSI14:68.47
MTM14:0.57
ROC14:0.05
ATR:0.44
Week High:12.53
Week Low:11.74
Month High:12.53
Month Low:8.55
Year High:12.53
Year Low:6.42
Volatility:9.88